What to Expect With Carcinoid Tumor / Neuroendocrine Tumor (NET) End-of-Life Care
By CRYSTAL BAI •
The short answer: Neuroendocrine tumors (NETs), including carcinoid tumors, are often slow-growing but can progress to a stage where treatment is no longer effective. End-of-life care for advanced NETs focuses on managing carcinoid syndrome symptoms (flushing, diarrhea), liver disease from metastases, hormonal complications, and supporting patients through a disease that may have a prolonged end-of-life phase.
What to Expect With Carcinoid Tumor / Neuroendocrine Tumor (NET) End-of-Life Care
Neuroendocrine tumors are a diverse family of cancers arising from hormone-producing cells throughout the body. Carcinoid tumors (a subtype of NET) classically arise in the gut or lungs. While many NETs are slow-growing, grade 3 (poorly differentiated) NETs and advanced well-differentiated NETs that have exhausted treatment options require specialized end-of-life care.
NET Disease Trajectory
NETs vary enormously by grade and primary site. Grade 1-2 NETs may progress over years or even decades; grade 3 NETs can behave aggressively. Treatment options include somatostatin analogs (octreotide, lanreotide), targeted therapies (everolimus, sunitinib), PRRT (peptide receptor radionuclide therapy), and chemotherapy. When these fail, palliative care becomes primary.
Carcinoid Syndrome Management
Carcinoid syndrome — caused by serotonin and other hormones secreted by functioning NETs — produces flushing, severe diarrhea, wheezing, and carcinoid heart disease. At end of life, managing these symptoms is critical:
Flushing: Octreotide and newer SSAs provide significant relief. Avoiding triggers (alcohol, stress, physical exertion) helps.
Diarrhea: Can be severe and dehydrating. High-dose octreotide, loperamide, tincture of opium, and ondansetron help manage.
Carcinoid crisis: A life-threatening surge of vasoactive substances triggered by surgery, anesthesia, or emotional stress. Requires IV octreotide. Emergency teams must be aware.
Liver Disease From Metastases
The liver is the most common metastatic site for NETs. Bulky liver disease causes hepatomegaly, pain from capsular distension, and eventually liver dysfunction. Right upper quadrant pain management with scheduled opioids is central. Palliative liver-directed procedures may provide temporary relief.
Carcinoid Heart Disease
Serotonin exposure causes fibrotic damage to the right heart valves (carcinoid heart disease), leading to right heart failure with peripheral edema, ascites, and breathlessness. Diuretics manage fluid overload. At end of life, comfort-focused fluid management is primary.
The Prolonged Trajectory
Unlike many cancers, NETs can have a prolonged end-of-life phase — patients may live comfortably for a year or more even with advanced disease. This extended trajectory requires ongoing palliative symptom management and psychosocial support. Death doulas can provide long-term support through this extended phase.
Frequently Asked Questions
What is carcinoid syndrome?
Carcinoid syndrome is a collection of symptoms caused by neuroendocrine tumors that secrete serotonin and other vasoactive substances directly into the bloodstream (bypassing liver detoxification). Symptoms include episodic flushing (redness of face and neck), severe diarrhea, wheezing, and heart complications (carcinoid heart disease). It occurs primarily when NETs have spread to the liver.
What is carcinoid crisis and why does it matter?
Carcinoid crisis is a life-threatening surge of vasoactive substances that can be triggered by surgery, anesthesia, imaging procedures, or significant stress in NET patients. It causes dangerous blood pressure changes, severe flushing, and bronchospasm. Medical teams treating NET patients — including emergency and hospice providers — must know to pretreat with IV octreotide before any procedures.
How is carcinoid diarrhea managed at end of life?
Carcinoid diarrhea is managed with high-dose somatostatin analogs (octreotide, pasireotide), antidiarrheals (loperamide, tincture of opium), and antiemetics. At end of life, maintaining hydration and comfort is the primary goal. Hospice teams experienced with NETs can optimize this often challenging symptom that significantly affects quality of life.
What is carcinoid heart disease?
Carcinoid heart disease is fibrotic damage to the right heart valves — particularly the tricuspid and pulmonary valves — caused by chronic exposure to serotonin from functioning NETs. It leads to right-sided heart failure with peripheral edema, ascites, and breathlessness. Surgical valve replacement may be considered in carefully selected patients; in advanced disease, it is managed medically with diuretics.
How long do people live with advanced NETs?
Prognosis with advanced NETs varies enormously by tumor grade and primary site. Grade 1-2 (well-differentiated) NETs, even with liver metastases, may allow patients to live comfortably for years. Grade 3 (poorly differentiated) NETs progress more rapidly. This wide variation means individualized prognosis discussions with the oncology team are essential; generic statistics are not useful for individual patients.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.